Araki H, Peck R C, Lefer A M, Smith J B
Prostaglandins. 1981 Mar;21(3):387-99. doi: 10.1016/0090-6980(81)90084-8.
Dexamethasone at a dose of 6 mg.kg-1 given to rabbits for three days prior to challenge with sodium arachidonate (2 mg.kg-1) intravenously, improved survival from 0% to 90% (p less than 0.01). Dexamethasone, given for shorter periods prior to arachidonate injection resulted in survival rates from 17% to 40%. In dexamethasone (3 days) treated rabbits, plasma thromboxane B2 concentrations were only increased by 30% compared with increases of 950% in untreated rabbits (p less than 0.001). Dexamethasone treated rabbits did not exhibit pulmonary thrombosis as did untreated rabbits given arachidonate. However, platelet rich plasma from both control and treated rabbits was aggregated by 0.2 mM arachidonate in vitro. The mechanism of the protective effect of dexamethasone appears to be related to induction of enzymes or stimulation of clearance of injected arachidonic acid, since steroid treated rabbits cleared labeled arachidonic acid more rapidly than untreated rabbits.
在静脉注射花生四烯酸钠(2毫克·千克-1)攻击前三天,给兔子注射剂量为6毫克·千克-1的地塞米松,可使存活率从0%提高到90%(p小于0.01)。在注射花生四烯酸之前较短时间给予地塞米松,存活率为17%至40%。在地塞米松(3天)治疗的兔子中,血浆血栓素B2浓度仅增加30%,而未治疗的兔子增加950%(p小于0.001)。地塞米松治疗的兔子不像未治疗的注射花生四烯酸的兔子那样出现肺血栓形成。然而,来自对照和治疗兔子的富血小板血浆在体外均被0.2毫摩尔的花生四烯酸聚集。地塞米松保护作用的机制似乎与酶的诱导或注入花生四烯酸清除的刺激有关,因为用类固醇治疗的兔子比未治疗的兔子更快地清除标记的花生四烯酸。